Stay updated on Initial Myeloma: High-Dose vs Conventional RVD Clinical Trial
Sign up to get notified when there's something new on the Initial Myeloma: High-Dose vs Conventional RVD Clinical Trial page.

Latest updates to the Initial Myeloma: High-Dose vs Conventional RVD Clinical Trial page
- Check3 days agoChange DetectedA new revision entry (v3.3.4) was added to the history and the earlier revision (v3.3.3) was removed. This updates the page’s version history.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedRevision: v3.3.3 added; HHS Vulnerability Disclosure and Revision: v3.3.2 removed from the page footer.SummaryDifference0.2%

- Check54 days agoChange DetectedThe record history shows a new revision entry v3.3.2 replacing v3.2.0, a minor metadata update to the page that does not affect study data, status, or content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check61 days agoChange DetectedRemoved the government funding lapse notice at the top of the page; no new study data or content was added. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check83 days agoChange DetectedThe new screenshot shows the same Record History with identical version entries and no changes to core trial data or status. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check104 days agoChange DetectedMajor update: new operational notice and new version v3.2.0 replacing v3.1.0; new content about funding status and operating status, with links to cc.nih.gov and opm.gov.SummaryDifference12%

Stay in the know with updates to Initial Myeloma: High-Dose vs Conventional RVD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Initial Myeloma: High-Dose vs Conventional RVD Clinical Trial page.